1. Home
  2. FRBT vs AMPH Comparison

FRBT vs AMPH Comparison

Compare FRBT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FRBT

Forbright Inc. Class A Common Stock

N/A

Current Price

$19.08

Market Cap

906.8M

Sector

Finance

ML Signal

N/A

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$20.57

Market Cap

885.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRBT
AMPH
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.8M
885.4M
IPO Year
2026
2005

Fundamental Metrics

Financial Performance
Metric
FRBT
AMPH
Price
$19.08
$20.57
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$28.38
AVG Volume (30 Days)
112.5K
382.8K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.14
Revenue
N/A
$719,887,000.00
Revenue This Year
N/A
$6.90
Revenue Next Year
N/A
$4.64
P/E Ratio
N/A
$144.00
Revenue Growth
N/A
N/A
52 Week Low
$17.72
$16.65
52 Week High
$22.00
$31.26

Technical Indicators

Market Signals
Indicator
FRBT
AMPH
Relative Strength Index (RSI) 49.35 57.22
Support Level $18.29 $18.12
Resistance Level $21.22 $20.77
Average True Range (ATR) 1.45 0.64
MACD -0.05 0.08
Stochastic Oscillator 15.63 94.71

Price Performance

Historical Comparison
FRBT
AMPH

About FRBT Forbright Inc. Class A Common Stock

Forbright Inc is a bank holding company. Along with its subsidiaries, it operates as a state chartered non-member bank, which serves the needs of individuals, small and medium sized businesses, and professional concerns. Its services include deposit and retail banking through a digital deposit platform, as well as financing and lending products such as lender finance loans, fund finance loans, healthcare finance loans, real estate loans, working capital facilities, warehouse lines of credit, and term loans.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: